Cargando…

Serological Testing Versus Other Strategies for Diagnosis of Active Tuberculosis in India: A Cost-Effectiveness Analysis

BACKGROUND: Undiagnosed and misdiagnosed tuberculosis (TB) drives the epidemic in India. Serological (antibody detection) TB tests are not recommended by any agency, but widely used in many countries, including the Indian private sector. The cost and impact of using serology compared with other diag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dowdy, David W., Steingart, Karen R., Pai, Madhukar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153451/ https://www.ncbi.nlm.nih.gov/pubmed/21857810 http://dx.doi.org/10.1371/journal.pmed.1001074

Ejemplares similares

Serological tests for the diagnosis of active tuberculosis: relevance for India
por: Steingart, Karen R., et al.
Publicado: (2012)

Is Scale-Up Worth It? Challenges in Economic Analysis of Diagnostic Tests for Tuberculosis
por: Dowdy, David W., et al.
Publicado: (2011)

Costs and Consequences of Using Interferon-γ Release Assays for the Diagnosis of Active Tuberculosis in India
por: Little, Kristen M., et al.
Publicado: (2015)

Commercial Serological Tests for the Diagnosis of Active Pulmonary and Extrapulmonary Tuberculosis: An Updated Systematic Review and Meta-Analysis
por: Steingart, Karen R., et al.
Publicado: (2011)

Commercial Serological Antibody Detection Tests for the Diagnosis of Pulmonary Tuberculosis: A Systematic Review
por: Steingart, Karen R, et al.
Publicado: (2007)

Correction: Commercial Serological Antibody Detection Tests for the Diagnosis of Pulmonary Tuberculosis: A Systematic Review
por: Steingart, Karen R, et al.
Publicado: (2007)

Promoting Affordable and Quality Tuberculosis Testing in India
por: Pai, Madhukar
Publicado: (2013)

Cost-effectiveness of triage testing for facility-based systematic screening of tuberculosis among Ugandan adults
por: Murray, Matthew, et al.
Publicado: (2016)

Informing decision-making for universal access to quality tuberculosis diagnosis in India: an economic-epidemiological model
por: Sohn, Hojoon, et al.
Publicado: (2019)

Commercial serological tests for the diagnosis of active tuberculosis in India: Time for introspection
por: Singh, Sarman, et al.
Publicado: (2011)

Use of Rapid, Point-of-Care Assays by Private Practitioners in Chennai, India: Priorities for Tuberculosis Diagnostic Testing
por: Bronner Murrison, Liza, et al.
Publicado: (2016)

Do We Need to Detect Isoniazid Resistance in Addition to Rifampicin Resistance in Diagnostic Tests for Tuberculosis?
por: Denkinger, Claudia M., et al.
Publicado: (2014)

Why are inaccurate tuberculosis serological tests widely used in the Indian private healthcare sector? A root-cause analysis
por: Jarosławski, Szymon, et al.
Publicado: (2012)

Accuracy of line probe assays for the diagnosis of pulmonary and multidrug-resistant tuberculosis: a systematic review and meta-analysis
por: Nathavitharana, Ruvandhi R., et al.
Publicado: (2017)

The Importance of Implementation Strategy in Scaling Up Xpert MTB/RIF for Diagnosis of Tuberculosis in the Indian Health-Care System: A Transmission Model
por: Salje, Henrik, et al.
Publicado: (2014)

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
por: Steingart, Karen R, et al.
Publicado: (2014)

India’s syndemic of tuberculosis and COVID-19
por: Shrinivasan, Rukmini, et al.
Publicado: (2020)

Xpert® Mtb/Rif assay for pulmonary tuberculosis and rifampicin resistance in adults
por: Steingart, Karen R, et al.
Publicado: (2013)

Lessons on the quality of tuberculosis diagnosis from standardized patients in China, India, Kenya, and South Africa
por: Daniels, Benjamin, et al.
Publicado: (2019)

India is well placed to scale innovations in tuberculosis diagnostics
por: Pai, Madhukar, et al.
Publicado: (2023)

The End TB Strategy: India can blaze the trail
por: Pai, Madhukar
Publicado: (2015)

Tuberculosis diagnosis and management in the public versus private sector: a standardised patients study in Mumbai, India
por: Daniels, Benjamin, et al.
Publicado: (2022)

Nosocomial Tuberculosis in India
por: Pai, Madhukar, et al.
Publicado: (2006)

Testing and Treating the Missing Millions with Tuberculosis
por: Pai, Madhukar, et al.
Publicado: (2015)

India's fight against tuberculosis: How can chest physicians help?
por: Pai, Madhukar, et al.
Publicado: (2017)

Evidence-Based Tuberculosis Diagnosis
por: Pai, Madhukar, et al.
Publicado: (2008)

Self-reported tuberculosis in India: evidence from NFHS-4
por: Mazumdar, Sumit, et al.
Publicado: (2019)

India's plan to eliminate tuberculosis by 2025: converting rhetoric into reality
por: Pai, Madhukar, et al.
Publicado: (2017)

Cost-Effectiveness of HIV Testing Referral Strategies among Tuberculosis Patients in India
por: Uhler, Lauren M., et al.
Publicado: (2010)

Multicomponent strategy with decentralised molecular testing for tuberculosis in Uganda: a cost and cost-effectiveness analysis
por: Thompson, Ryan R, et al.
Publicado: (2023)

Improving the quality of tuberculosis care: We need standards and strategies to translate them into practice
por: Pai, Madhukar
Publicado: (2014)

Costs and cost-effectiveness of a comprehensive tuberculosis case finding strategy in Zambia
por: Jo, Youngji, et al.
Publicado: (2021)

Cost-Effectiveness of Automated Digital Microscopy for Diagnosis of Active Tuberculosis
por: Jha, Swati, et al.
Publicado: (2016)

Xpert®MTB/RIF for the Diagnosis of Tuberculosis in a Remote Arctic Setting: Impact on Cost and Time to Treatment Initiation
por: Oxlade, Olivia, et al.
Publicado: (2016)

Ending tuberculosis in India: A political challenge & an opportunity
por: Dias, Hannah Monica Yesudian, et al.
Publicado: (2018)

Tuberculosis therapy in Mumbai: Critical importance of drug-susceptibility testing
por: Daftary, Amrita, et al.
Publicado: (2016)

Mind the gap: Time to address implementation gaps in tuberculosis diagnosis and treatment
por: Pai, Madhukar, et al.
Publicado: (2016)

Learning from COVID-19 to reimagine tuberculosis diagnosis
por: Ruhwald, Morten, et al.
Publicado: (2021)

Serial testing for latent tuberculosis using QuantiFERON-TB Gold In-Tube: A Markov model
por: Moses, Mark W., et al.
Publicado: (2016)

Commercial Nucleic-Acid Amplification Tests for Diagnosis of Pulmonary Tuberculosis in Respiratory Specimens: Meta-Analysis and Meta-Regression
por: Ling, Daphne I., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_ofi38tjlv7dc3h279ev5so58fj